0001042167-13-000058.txt : 20130401 0001042167-13-000058.hdr.sgml : 20130401 20130401170508 ACCESSION NUMBER: 0001042167-13-000058 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130326 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20130401 DATE AS OF CHANGE: 20130401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: FEMALE HEALTH CO CENTRAL INDEX KEY: 0000863894 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 391144397 STATE OF INCORPORATION: WI FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13602 FILM NUMBER: 13732112 BUSINESS ADDRESS: STREET 1: 515 NORTH STATE STREET STREET 2: STE 2225 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 3125959123 MAIL ADDRESS: STREET 1: 515 NORTH STATE STREET STREET 2: SUITE 2225 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: WISCONSIN PHARMACAL COMPANY INC DATE OF NAME CHANGE: 19920703 8-K 1 form8k.htm FORM 8-K form8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

__________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  March 26, 2013

The Female Health Company
(Exact name of registrant as specified in its charter)

Wisconsin
  
1-13602
  
39-1144397
(State or other jurisdiction
of incorporation)
  
(Commission File Number)
  
(IRS Employer
Identification No.)

515 North State Street, Suite 2225, Chicago, Illinois 60654
(Address of principal executive offices, including zip code)

(312) 595-9123
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
 o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
 o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
 o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
 o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 


Section 5 – Corporate Governance and Management
 
Item 5.07.                   Submission of Matters to a Vote of Security Holders.
 
The Annual Meeting of Shareholders of The Female Health Company (the "Company") was held on March 26, 2013.  A total of 28,669,916 shares of common stock were eligible to vote at the Annual Meeting.  The matters voted on at the Annual Meeting were as follows:

1.           Election of Directors:

The following individuals were nominated for election to the Board of Directors for terms that expire at the next annual meeting of shareholders.

 
Name
  
Votes
      For      
  
Votes
    Withheld    
  
Broker
   Non-Votes   
David R. Bethune
  
17,059,660
  
498,317
  
7,792,715
Stephen M. Dearholt
  
17,302,823
  
255,154
  
7,792,715
Donna Felch
  
16,952,198
  
605,779
  
7,792,715
Mary Margaret Frank, Ph.D.
  
17,313,594
  
244,383
  
7,792,715
William R. Gargiulo, Jr.
  
17,191,971
  
366,006
  
7,792,715
Mary Ann Leeper, Ph.D.
  
16,895,543
  
662,434
  
7,792,715
O.B. Parrish
  
17,409,814
  
148,163
  
7,792,715
Michael R. Walton
  
17,273,803
  
284,174
  
7,792,715
Richard E. Wenninger
  
17,305,238
  
252,739
  
7,792,715

The nominations were made by the Board of Directors and no other nominations were made by any shareholder. The nominees had currently been members of the Board of Directors at the date of the Annual Meeting.

2.           Ratification of Auditors:

The shareholders voted to ratify the appointment by the Company's Audit Committee of McGladrey LLP as the Company's independent registered public accounting firm for the fiscal year ending September 30, 2013.

    Votes For    
  
  Votes Against
  
    Abstentions  
  
   Broker Non-Votes  
25,212,332
  
96,453
  
41,907
  
-


                                                               
2 
 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

THE FEMALE HEALTH COMPANY

Date:  April 1, 2013
BY /s/ Michele Greco                                                            
      Michele Greco, Vice President and
      Chief Financial Officer


3